Aktie
Zugehörige Wertpapiere Summit Therapeutics
- WKN
- A2QDFS
- ISIN
- US86627T1088
- Ticker
- SMMT
- WKN
- A2QDFS
- Ticker
- SMMT
- ISIN
- US86627T1088
• Nasdaq
18,215 USD
-7,995 USD-30,50 %
Geld
18,500 USD
(900 Stk.)
Brief
18,540 USD
(1.500 Stk.)
Tagesvolumen
19.854.456 Stk.
Tagesspanne
18,010 – 21,630 USD
52W-Spanne
6,780 – 36,910 USD
Zugehörige ETF zur Summit Therapeutics Aktie
| Name | KVG | Anteil am ETF |
|---|---|---|
iShares NASDAQ US Biotechnology UCITS ETF USD Acc. WKN A2DWAW · ISIN IE00BYXG2H39 | BlackRock | 1,91 % |
iShares NASDAQ US Biotechnology UCITS ETF USD Dis. WKN A2JDYM · ISIN IE00BDZVHG35 | BlackRock | 1,91 % |
HANetf HAN-GINS Tech Megatrend Equal Weight UCITS ETF USD Acc. WKN A2JR0J · ISIN IE00BDDRF700 | HANetf Ltd | 1,04 % |
Zugehörige Fonds zur Summit Therapeutics Aktie
| Name | KVG | Anteil am Fonds |
|---|---|---|
Protea Fund - Sectoral Biotech Opportunities Fund - IF EUR ACC WKN A14NHD · ISIN LU1176837026 | Pictet | 2,83 % |
Protea Fund - Sectoral Biotech Opportunities Fund - PF EUR ACC WKN A14NHE · ISIN LU1176838347 | Pictet | 2,83 % |
Protea Fund - Sectoral Biotech Opportunities Fund - IF USD ACC WKN A14NHF · ISIN LU1176839154 | Pictet | 2,83 % |
Protea Fund - Sectoral Biotech Opportunities Fund - PF USD ACC WKN A14NHG · ISIN LU1176840327 | Pictet | 2,83 % |
Protea Fund - Sectoral Biotech Opportunities Fund - IF CHF ACC H WKN A2JKJ0 · ISIN LU1711916616 | Pictet | 2,83 % |